COVID-19 Information Hub

AstraZeneca is responding to the COVID-19 (novel coronavirus) outbreak, consistent with our values to follow the science, put patients first and do the right thing. Our priorities are to ensure the continued supply of our medicines to patients, and to safeguard the health and wellbeing of all our employees and communities. On this page we provide an overview of AstraZeneca news and relevant information.
 

Latest news

Researching antibodies to target COVID-19

AstraZeneca is joining forces with government and academia with the aim of discovering novel coronavirus-neutralising antibodies.

AstraZeneca/ GSK/ University of Cambridge collaborate to support UK national effort to boost COVID-19 testing

AstraZeneca to donate 9 million face masks to support healthcare workers around the world in the fight against COVID-19

Our update on COVID-19

AstraZeneca is responding to the COVID-19 (novel coronavirus) outbreak, consistent with our values to follow the science, put patients first and do the right thing. Our priorities are to ensure the continued supply of our medicines to patients, and to safeguard the health and wellbeing of all our employees and communities.

Healthcare providers

If you are a registered healthcare provider with questions about COVID-19 and AstraZeneca medications, please visit AstraZeneca’s medical information site: AZmedical.com.

COVID-19 clinical MDT experience sharing webcast

8 top experts from China, Korea, Japan, Italy, Singapore to discuss the challenges and share experience of different countries. This content is intended for HealthCare Professionals for medical educational purposes only. The content is from an independent webcast organised by Huashan Hospital and was broadcasted on 07 March 2020.